atl1102 new stem cell mobilization indication, page-69

Frustrating, disappointing, confusing BUT compelling.
I am no Einstein but with investing in a company worth 10 mill that has proven 'potential' and a strategic plan with income of approx 500M Annum it gives me reason to stay focused that my investment must grow.
Is this stock being played by one suitor (potential partner) ?
Is it market forces?
Is it one broker accumulating ?
Fact is, I do care as it really astonishes me how we can retain this market cap.
But surely I / we are not fools????
A partnership is what we need to mitigate future dilution and bolster our forward plan. Who will that be?
If I had 10mill or so, possibly me.
Why.
In the very near future (b4 Xmas) we may well prove a market in acramology worth vis 200M / annum via Alt1103
We can expect news on possible 'cancer prevention' benefits within same drug and same timeframe
We can expect news of potential for Alt103 in treatment for retinal diabetics/lung cancer
We MAY well expect news of partnerships on EITHER for altt103 or Alt102.
We are currently valued at 1/20th of forward earnings within 3yrs (being conservative)
Looking at a glass half full, the capper has prevented rapid growth to strengthen our capitalization.
Being already invested, Time is the one thing we have on our side. Now to be patient.
Short term pain for long (medium) term gain.